ClinicalTrials.Veeva

Menu

Evaluating Interventions for Intimate Partner Violence Use in Washington State

Boston University logo

Boston University

Status

Enrolling

Conditions

Intimate Partner Violence

Treatments

Behavioral: Strength at Home (SAH)
Behavioral: Treatment as usual for IPV

Study type

Interventional

Funder types

Other

Identifiers

NCT06526247
H-44938

Details and patient eligibility

About

Intimate partner violence (IPV), specifically physical and psychological aggression toward an intimate partner, represents a public health crisis that affects millions of Americans each year. There currently exists very little evidence from randomized controlled trials for the effectiveness of abuser intervention programs designed to prevent and end perpetration of IPV in the general population. This is troubling considering that approximately half a million men and women are court-mandated to these programs each year.

The investigators will conduct a randomized control trial (RCT) investigating the efficacy of the Strength at Home (SAH) intervention in reducing intimate partner violence (IPV). The overarching aim of this study is to test the efficacy of SAH with court-involved-partner-violent men through an RCT comparing those who receive SAH with those who receive other standard IPV interventions offered in the state of Washington (treatment as usual- TAU).

The specific aims are:

1.1: Compare the frequency of physical and psychological IPV, the primary outcomes of interest, across conditions as reported by the male participants and their intimate partners across Time 1 (baseline) and four 3-month follow ups (Times 2-5). It is expected that greater reductions in IPV frequencies will be evidenced in SAH than TAU over the course of the year.

1.2: Compare symptoms of PTSD, alexithymia, and alcohol use problems across conditions and assessment time points as reported by the male participants. It is expected that greater reductions in these symptoms will be evidenced in SAH than TAU over the course of the year.

1.3: Compare treatment satisfaction across conditions as reported by the male participants across the four 3-month follow ups (Times 2-5). It is expected that treatment satisfaction will be higher in SAH than TAU.

Enrollment

800 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Men:

  1. Identify as a man
  2. Provide consent for the research team to contact his intimate partner(s) for data collection purposes;
  3. Court-referred for IPV intervention in Washington state

Women:

  1. Identify as a woman
  2. Were or currently are an intimate partner involved in an incident of IPV with a court-referred participant

Exclusion criteria

  1. demonstrates active psychosis that may interfere with their ability to participate in group
  2. expresses prominent suicidal or homicidal ideation that requires hospitalization
  3. does not possess proficiency in spoken English
  4. periods of incarceration after study enrollment

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

800 participants in 2 patient groups

Strength at Home (SAH)
Experimental group
Description:
Participants randomized into this arm with receive a trauma-informed intimate partner violence (IPV) intervention program.
Treatment:
Behavioral: Strength at Home (SAH)
Treatment as Usual (TAU)
Active Comparator group
Description:
Participants randomized into this arm with receive a standard IPV intervention program in the state of Washington.
Treatment:
Behavioral: Treatment as usual for IPV

Trial contacts and locations

1

Loading...

Central trial contact

Casey Taft, PhD; Megan Kopitsky, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems